Medication Travel Letter

January 1, 2050

Hunter Pierce

Case Officer

The Embassy

909 Cedar Lane

Springfield, CA 90230

Dear Mr. Pierce,

This letter validates the need for our employee's travel, Mr. Oliver Parsons. He serves our corporation as a Senior Research Analyst in the Novel Drug Discovery Department. His trip to Ireland is paramount and should be treated as essential.

Mr. Parsons's primary purpose for this trip is to continue his essential duties in a crucial medication trial conducted in our affiliate laboratory in Dublin, Ireland. The investigation pertains to groundbreaking research that could revolutionize the treatment of various neurological disorders.

The travel period is tentatively set for six months, from February 1, 2050, to August 1, 2050. During this tenure, Mr. Parsons will be immersed in the development of the medication, guiding the trial and participating in essential discussions with other leading researchers in the field.

If additional verification or more information is required, please get in touch with our office at your earliest convenience. We appreciate your understanding and cooperation in this matter.

Best Regards,

Dr. Hannah Stevens

Director

Mediaid Pharmaceutical Corporation